531015
VENMAX
Start SIP
Invest Now
Start SIP in VENMAX
Performance
- Low
- ₹26
- High
- ₹29
- 52 Week Low
- ₹13
- 52 Week High
- ₹37
- Open Price₹28
- Previous Close₹28
- Volume2,369
Investment Returns
- Over 1 Month -4.28%
- Over 3 Month + 16.1%
- Over 6 Month + 4.36%
- Over 1 Year + 86.81%
Smart Investing Starts Here Start SIP with Venmax Drugs & Pharmaceuticals for Steady Growth!
Venmax Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42.2
- PEG Ratio
- 0.2
- Market Cap Cr
- 15
- P/B Ratio
- 2.5
- Average True Range
- 1.94
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.02
- RSI
- 48.87
- MFI
- 24.77
Venmax Drugs & Pharmaceuticals Financials
Venmax Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹27.76
+
0.07
(0.25%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹27.94
- 50 Day
- ₹27.63
- 100 Day
- ₹27.02
- 200 Day
- ₹24.89
Resistance and Support
27.7
- R3 31.85
- R2 30.45
- R1 29.10
- S1 26.35
- S2 24.95
- S3 23.60
Venmax Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-09-02 | Amalgamation & A.G.M. | |
| 2025-08-16 | Others | Inter alia, to consider and approve 1. Allotment of Equity Shares pursuant to conversion of Convertible Equity Share Warrants. |
| 2025-07-23 | Quarterly Results | |
| 2025-05-09 | Audited Results |
Venmax Drugs & Pharmaceuticals F&O
About Venmax Drugs & Pharmaceuticals
- NSE Symbol
- VENMAX
- BSE Symbol
- 531015
- ISIN
- INE154G01022
Similar Stocks to Venmax Drugs & Pharmaceuticals
Venmax Drugs & Pharmaceuticals FAQs
Venmax Drugs & Pharmaceuticals share price is ₹27 As on 26 December, 2025 | 01:18
The Market Cap of Venmax Drugs & Pharmaceuticals is ₹14.5 Cr As on 26 December, 2025 | 01:18
The P/E ratio of Venmax Drugs & Pharmaceuticals is 42.2 As on 26 December, 2025 | 01:18
The PB ratio of Venmax Drugs & Pharmaceuticals is 2.5 As on 26 December, 2025 | 01:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.